Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Rex to pursue FIFO opportunities with new acquisition. Could their spat with Qantas be coming in to land?
    • News

    Rex to pursue FIFO opportunities with new acquisition. Could their spat with Qantas be coming in to land?

    After vehemently accusing Qantas (ASX: QAN) of anti competitive behaviour, Regional Express Airlines (ASX: REX) have lodged their own competitive bid.  The Company is intent on acquiring National Jet Express, the regional division of Cobham Services Australia.  National Jet Express is a key provider of Fly-In, Fly-Out services to Western Australian and South Australian workers.

    Read More
    Public
  • IDX revenue remains steady despite ongoing spicy flu woes
    • News

    IDX revenue remains steady despite ongoing spicy flu woes

    As one of Australia’s leading providers of medical imaging and diagnostic services, Integral Diagnostics (ASX: IDX) plays a vital role in supporting clinicians to provide optimal treatment for their patients. With 67 radiology clinics under their umbrella, IDX is a prominent provider of radiology services to multiple communities across Western Victoria, Queensland, Western Australia and

    Read More
    Public
  • Eco-friendly Fibre Company Locking in Solid Results
    • News

    Eco-friendly Fibre Company Locking in Solid Results

    Australian-based bio-materials technology Company Nanollose (ASX: NC6) has announced its quarterly results today, as a show of its advancements in the textile industry and its revolutionary development of eco-friendly material.  Nanollose has spent the last few years attempting to penetrate the $500 billion textile industry by developing eco-friendly processes to grow cellulose fibres from waste

    Read More
    Public
  • Why this Tasmanian whisky brand had a record sales quarter
    • News

    Why this Tasmanian whisky brand had a record sales quarter

    I’m here to break the stereotype that whisky is a man’s drink, because ladies- a whisky over ice absolutely SLAPS.  I’d highly recommend grabbing a bottle of Lark’s (ASX: LRK) Tasmanian single malt whisky and giving it a go instead of your usual glass of red. Trust me.  Nominated as one of the top fourRead More
    Public
  • 4DMedical gains momentum as commercialisation gets underway
    • News

    4DMedical gains momentum as commercialisation gets underway

    Unfortunately, COVID seems to be here to stay, with re-infections becoming the new norm, and people dropping like flies. (I, of course, being of superior birth, am yet to contract the spicy flu, but time will tell.) The pandemic saw growth in a few industries like eCommerce, however an interesting subset of pandemic profiteers emerged,

    Read More
    Public
  • After 15-month suspension, DomaCom eyes re-listing on ASX with $134 million FUM
    • News

    After 15-month suspension, DomaCom eyes re-listing on ASX with $134 million FUM

    For shareholders of fractional investment company DomaCom (ASX: DCL), it’s been a difficult FY22 which has thankfully come to an end given the Company’s 10-day voluntary suspension ultimately turned in a year-long ordeal but with a new financial year upon us, the Company is hopeful of finally re-listing alongside the release of their FY23 strategic

    Read More
    Public
  • «
  • ‹
  • 353
  • 354
  • 355
  • 356
  • 357
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.